Robuta

https://www.ncbi.nlm.nih.gov/Structure/pdb/5O5P
Capsid proteins, VP4Capsid proteins, VP1Capsid proteins, VP2Capsid proteins,...
virus like particlepoliovirustypestrainstabilized
https://www.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2022.975054/full
Transmission electron microscopy (TEM) is a gold standard analytical method for nanoparticle characterization and is playing a valuable role in virus-like pa...
virus like particlequality assessmentfrontiersnewtransmission
https://www.ncbi.nlm.nih.gov/Structure/pdb/1WCD
MAJOR STRUCTURAL PROTEIN VP2
virus like particlecrystal structureibdvreveals
https://pubmed.ncbi.nlm.nih.gov/25240757/
VLP vaccines bearing influenza HA glycoproteins can elicit transient IgG and, in some cases, IgE responses that are not associated with either the development...
antibody responsehumanglycanspresentplant
https://www.ncbi.nlm.nih.gov/Structure/pdb/8OPD
Genome polyprotein (Fragment)
virus like particlecoat proteinbasedpvy
https://pubmed.ncbi.nlm.nih.gov/17602732/
The adjuvanted HPV16/18 vaccine showed prophylactic efficacy against CIN2+ associated with HPV16 or HPV18 and thus could be used for cervical cancer prevention.
virus like particleefficacyprophylacticadjuvantedbivalent
https://pubmed.ncbi.nlm.nih.gov/29399414/
Overexpression of human epidermal growth factor receptor-2 (HER2) occurs in 20-30% of invasive breast cancers. Monoclonal antibody therapy is effective in...
virus like particleanti cancerdisplayinducespotent
https://www.ncbi.nlm.nih.gov/Structure/pdb/6YFH
virus like particlebacteriophage
https://www.mdpi.com/1999-4915/15/10/2013
Yellow Fever (YF) is a severe disease that, while preventable through vaccination, lacks rapid intervention options for those already infected. There is an...
yellow fever virusproduction processbioreactorbasedlike
https://www.mdpi.com/2076-393X/9/6/539
Capsid virus-like particles (cVLPs) are used as molecular scaffolds to increase the immunogenicity of displayed antigens. Modular platforms have been developed...
headcomparisonmodularvaccinesdeveloped